MariMed Inc.

MRMD


Canadian symbol: MRMD
US symbol: MRMD

Currency in USD

Valuation Measures4

Market Cap (intraday) 143.42M
Enterprise Value 169.42M
Trailing P/E 10.50
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.19
Price/Book (mrq)2.44
Enterprise Value/Revenue 1.26
Enterprise Value/EBITDA 6.54

Trading Information

Stock Price History

Beta (5Y Monthly) 3.04
52-Week Change 3-49.06%
S&P500 52-Week Change 3-13.08%
52 Week High 30.7760
52 Week Low 30.2800
50-Day Moving Average 30.4269
200-Day Moving Average 30.5132

Share Statistics

Avg Vol (3 month) 3270.82k
Avg Vol (10 day) 3310.43k
Shares Outstanding 5341.48M
Implied Shares Outstanding 6N/A
Float 8301.9M
% Held by Insiders 117.91%
% Held by Institutions 10.82%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Dec 30, 2022

Profitability

Profit Margin 10.05%
Operating Margin (ttm)15.92%

Management Effectiveness

Return on Assets (ttm)9.68%
Return on Equity (ttm)16.11%

Income Statement

Revenue (ttm)134.01M
Revenue Per Share (ttm)0.40
Quarterly Revenue Growth (yoy)15.40%
Gross Profit (ttm)63.96M
EBITDA 26.04M
Net Income Avi to Common (ttm)13.47M
Diluted EPS (ttm)0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.86M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)35.86M
Total Debt/Equity (mrq)37.73
Current Ratio (mrq)1.67
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)7.31M
Levered Free Cash Flow (ttm)-11.93M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
MRMD
MariMed
4 days ago
MRMD
MariMed
1 week ago
MRMD
MariMed
1 week ago
MRMD
MariMed
2 weeks ago
MRMD
MariMed
2 weeks ago
MRMD
MariMed
2 weeks ago
MRMD
MariMed
2 weeks ago
MRMD
MariMed
2 weeks ago
MRMD
MariMed
2 weeks ago
MRMD
MariMed
3 weeks ago
MRMD
MariMed
3 weeks ago
MRMD
MariMed
3 weeks ago
MRMD
MariMed
3 weeks ago
MRMD
MariMed
3 weeks ago
MRMD
MariMed
3 weeks ago
MRMD
MariMed
3 weeks ago
MRMD
MariMed
3 weeks ago
MRMD
MariMed
1 month ago
MRMD
MariMed
1 month ago
MRMD
MariMed
1 month ago
MRMD
MariMed
1 month ago
MRMD
MariMed
1 month ago
MRMD
MariMed
1 month ago
MRMD
MariMed
1 month ago
MRMD
MariMed
1 month ago
MRMD
MariMed
2 months ago
MRMD
MariMed
2 months ago
MRMD
MariMed
2 months ago
MRMD
MariMed
2 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
3 months ago
MRMD
MariMed
4 months ago
MRMD
MariMed
4 months ago
MRMD
MariMed
4 months ago
MRMD
MariMed
4 months ago
MRMD
MariMed
4 months ago
MRMD
MariMed
4 months ago
MRMD
MariMed
4 months ago
MRMD
MariMed
5 months ago
MRMD
MariMed
5 months ago
MRMD
MariMed
5 months ago
MRMD
MariMed
5 months ago
MRMD
MariMed
5 months ago
MRMD
MariMed
5 months ago
MRMD
MariMed
6 months ago
MRMD
MariMed
7 months ago
MRMD
MariMed
7 months ago
MRMD
MariMed
7 months ago
MRMD
MariMed
7 months ago
MRMD
MariMed
7 months ago
MRMD
MariMed
7 months ago
MRMD
MariMed
7 months ago
MRMD
MariMed
7 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
8 months ago
MRMD
MariMed
9 months ago
MRMD
MariMed
10 months ago
MRMD
MariMed
10 months ago
MRMD
MariMed
10 months ago
MRMD
MariMed
10 months ago
MRMD
MariMed
10 months ago
MRMD
MariMed
10 months ago
MRMD
MariMed
10 months ago
MRMD
MariMed
10 months ago
MRMD
MariMed
11 months ago
MRMD
MariMed
11 months ago
MRMD
MariMed
11 months ago
MRMD
MariMed
11 months ago
MRMD
MariMed
11 months ago
MRMD
MariMed
12 months ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
1 year ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
2 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago
MRMD
MariMed
3 years ago

Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2023)Next Qtr. (Jun 2023)Current Year (2023)Next Year (2024)
No. of Analysts2221
Avg. Estimate000.020.07
Low Estimate0000.07
High Estimate0.010.010.050.07
Year Ago EPS0.0100.040.02
Revenue EstimateCurrent Qtr. (Mar 2023)Next Qtr. (Jun 2023)Current Year (2023)Next Year (2024)
No. of Analysts2221
Avg. Estimate34.65M36.4M151.4M175M
Low Estimate33.3M35.8M148.8M175M
High Estimate36M37M154M175M
Year Ago Sales31.28M32.99M134.01M151.4M
Sales Growth (year/est)10.80%10.30%13.00%15.60%
Earnings History2022-03-302022-06-292022-09-292022-12-30
EPS Est.0.010.010.010
EPS Actual0.0100.010.01
Difference0-0.0100.01
Surprise %0.00%-100.00%0.00%N/A
EPS TrendCurrent Qtr. (Mar 2023)Next Qtr. (Jun 2023)Current Year (2023)Next Year (2024)
Current Estimate000.020.07
7 Days Ago000.020.07
30 Days Ago0.010.020.030.09
60 Days Ago0.010.020.040
90 Days Ago0.010.020.040
EPS RevisionsCurrent Qtr. (Mar 2023)Next Qtr. (Jun 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMRMDIndustrySector(s)S&P 500
Current Qtr.-100.00%N/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current Year-50.00%N/AN/AN/A
Next Year250.00%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in USD
Breakdown
17.91%% of Shares Held by All Insider
0.82%% of Shares Held by Institutions
1.00%% of Float Held by Institutions
6Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
Canton Hathaway, LLC645,100Dec 30, 20220.19%245,137
Smithbridge Asset Management, Inc.177,370Dec 30, 20220.05%67,400
Gofen & Glossberg LLC50,000Dec 30, 20220.01%18,999
NBW Capital LLC22,700Dec 30, 20220.01%8,625

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF1,300,000Dec 30, 20220.38%493,999
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by MariMed Inc.


MariMed Closes $35 Million Credit Facility to Accelerate its Strategic Growth Plans

MariMed Closes $35 Million Credit Facility to Accelerate its Strategic Growth Plans

NORWOOD, Mass., Jan. 24, 2023 -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announced that today it closed a $35 million secured credit facility with Chicago Atlantic Advisors, LLC (“Chicago Atlantic”) as the lead lender. “I am delighted to announce the closing of this tr... Read More...
MariMed Strengthens Sales, Marketing, and R&D Teams With Senior Executive Hires

MariMed Strengthens Sales, Marketing, and R&D Teams With Senior Executive Hires

Matt Truppo to Join as Vice President of Retail SalesJay O’Malley to Join as Vice President of Marketing and Research & Development NORWOOD, Mass., Jan. 17, 2023 -- MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today announced that two highly accomplished executives hav... Read More...
MariMed Adds Candy Cane Flavored Vape Pen To Its InHouse Brand Line-up for the Holiday Season

MariMed Adds Candy Cane Flavored Vape Pen To Its InHouse Brand Line-up for the Holiday Season

NORWOOD, Mass., Dec. 21, 2022 -- The Holiday Season just got merrier with the addition of a Candy Cane flavored disposable vape pen to the InHouse brand line-up of vapes and gummies launched by MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD) earlier this year. The limited edition InHouse Candy Cane disposable vape pen... Read More...
MariMed Mourns the Passing of Robert Fireman, Chairman, CEO And Cannabis Industry Pioneer and Visionary

MariMed Mourns the Passing of Robert Fireman, Chairman, CEO And Cannabis Industry Pioneer and Visionary

NORWOOD, Mass., Dec. 12, 2022 -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced with deep sadness that Chairman, Chief Executive Officer, and co-founder Robert Fireman died unexpectedly on December 11, 2022. The Company wil... Read More...
MariMed Supports Giving At Thanksgiving

MariMed Supports Giving At Thanksgiving

NORWOOD, Mass., Nov. 16, 2022 -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, wants people to focus on enjoying the Thanksgiving Holiday and not on the cost of their turkey. That is why the Company for the second consecutive year is dona... Read More...
Answering The Demand for Cannabis Products That Meet Evolving Consumer Needs, MariMed Adds New Products To Its Top-Selling Betty's Eddies Fruit Chews Line

Answering The Demand for Cannabis Products That Meet Evolving Consumer Needs, MariMed Adds New Products To Its Top-Selling Betty’s Eddies Fruit Chews Line

NORWOOD, Mass., Oct. 25, 2022 -- MariMed, Inc (CSE: MRMD), (OTCQX: MRMD), (“MariMed” or the “Company”) today announced the evolution of its top-selling Betty’s Eddies all-natural cannabis fruit chews brand to help cannabis consumers feel their “Betty best” no matter what life throws at them! Each fast-acting fruit chew has been custom-for... Read More...
MariMed Opens its First Medical Cannabis Dispensary in Maryland, Will Host a Grand Opening Event with Local Officials

MariMed Opens its First Medical Cannabis Dispensary in Maryland, Will Host a Grand Opening Event with Local Officials

NORWOOD, Mass., Oct. 05, 2022 -- MariMed, Inc (CSE: MRMD), (OTCQX: MRMD), (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced the opening of its first dispensary in Maryland. Operated by the Company’s wholly owned subsidiary, Kind Therapeutics USA (“Kind”), the 5,000 ... Read More...
MariMed To Launch Award-Winning Brands in Michigan Adult-Use Cannabis Market

MariMed To Launch Award-Winning Brands in Michigan Adult-Use Cannabis Market

NORWOOD, Mass., Sept. 13, 2022 -- MariMed, Inc (CSE: MRMD), (OTCQX: MRMD), (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced an agreement with 42 Degrees, a Michigan licensed cannabis producer and distributer, to manufacture and distribute MariMed’s award-winning br... Read More...
MariMed Appoints Jon Levine as President

MariMed Appoints Jon Levine as President

NORWOOD, Mass., Sept. 07, 2022 -- MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator (“MSO”) focused on improving lives every day, today announced the appointment of Jon Levine as President, effective immediately. Mr. Levine co-founded MariMed with Chief Executive Officer Bob Fir... Read More...
MariMed Introduces Nature's Heritage “LIVE Flower,” The Freshest Cannabis Available

MariMed Introduces Nature’s Heritage “LIVE Flower,” The Freshest Cannabis Available

NORWOOD, Mass., Aug. 30, 2022 -- MariMed, Inc. (“MariMed” or the “Company”) (CSE: MRMD, OTCQX: MRMD), a leading multi-state cannabis operator (“MSO”) focused on improving lives every day, today announced the launch of Nature’s Heritage “LIVE Flower,” the freshest cannabis flower available. Nature’s Heritage “LIVE Flower” buds are bigger a... Read More...
MariMed's Nature's Heritage Brand Sponsors Cultivators Cup, the Leading Cannabis Festival and Awards Competition in Massachusetts

MariMed’s Nature’s Heritage Brand Sponsors Cultivators Cup, the Leading Cannabis Festival and Awards Competition in Massachusetts

NORWOOD, Mass., Aug. 11, 2022 -- MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD), ("MariMed"), a leading multi-state cannabis operator, today announced its Nature’s Heritage brand of craft flower and concentrates is a Presenting Sponsor of Cultivators Cup, the leading cannabis industry festival and awards competition in Massachusetts. A celebrat... Read More...
MariMed and Legendary Emack & Bolio's Launch New Line-Up of Cannabis Infused Ice Creams

MariMed and Legendary Emack & Bolio’s Launch New Line-Up of Cannabis Infused Ice Creams

NORWOOD, Mass., Aug. 04, 2022 --  MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD), ("MariMed"), a leading multi-state cannabis operator focused on improving lives every day, today announced the availability of a new and scrumptious cannabis-infused ice cream. MariMed collaborated with the legendary Boston ice cream brand Emack & Bolio’s® to ... Read More...
MariMed Announces Kitchen Expansion in Maryland

MariMed Announces Kitchen Expansion in Maryland

NORWOOD, Mass., July 18, 2022 -- MariMed, Inc   (CSE: MRMD), (OTCQX: MRMD), (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced its wholly owned subsidiary, Kind Therapeutics USA (“Kind”), has received approval from the Maryland Medical Cannabis Commission (“MMCC”) to... Read More...
MariMed to Launch Top-Selling Betty's Eddies Brand Into Maine Adult-Use Cannabis Marketplace

MariMed to Launch Top-Selling Betty’s Eddies Brand Into Maine Adult-Use Cannabis Marketplace

NORWOOD, Mass., June 29, 2022 -- MariMed, Inc. (“MariMed” or the “Company”) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced a licensing agreement with East Coast Cannabis Company, a vertical cannabis producer and distributer in the Maine Cannabis market. The licensing agreement ... Read More...
MariMed Receives Media Awards For “World's Largest Cannabis Brownie” PR Campaign

MariMed Receives Media Awards For “World’s Largest Cannabis Brownie” PR Campaign

NORWOOD, Mass., May 24, 2022 -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today announced its recent “World’s Largest Cannabis Brownie” public relations campaign has earned two of the most prestigious national communications awards for its effectiveness in driving visibility of the C... Read More...
MariMed Awarded Dispensary License in Ohio

MariMed Awarded Dispensary License in Ohio

NORWOOD, Mass., May 18, 2022 -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, announced today it had been awarded a provisional dispensary license (“PDL”) by the Ohio Board of Pharmacy. MariMed won this license in the Ohio lottery process. The license... Read More...
MariMed Strengthens Executive Leadership Team To Support Accelerated Long-Term Growth

MariMed Strengthens Executive Leadership Team To Support Accelerated Long-Term Growth

Jon Levine Elevated to Chief Administration OfficerSusan Villare Appointed Chief Financial Officer NORWOOD, Mass., May 12, 2022 -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced the appointment of Jon Levine to the new role of Chief Adm... Read More...
MariMed Closes Acquisition of Illinois Craft Cannabis License Allowing for Vertically Integrated Operations

MariMed Closes Acquisition of Illinois Craft Cannabis License Allowing for Vertically Integrated Operations

NORWOOD, Mass., May 05, 2022 -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it has closed its acquisition of Green Growth Group, Inc. (“Green Growth”). The close of this transaction enables MariMed to add cultivation, manufacturing,... Read More...
MariMed Receives Maryland State Approval for Transfer of Ownership of Kind Therapeutics USA

MariMed Receives Maryland State Approval for Transfer of Ownership of Kind Therapeutics USA

NORWOOD, Mass., April 14, 2022 -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced that the Maryland Medical Cannabis Commission (MMCC) has approved the transfer of 100% of the ownership of Kind Therapeutics U.S.A., LLC (“Kind”), a leadin... Read More...
MariMed Files Preliminary Non-Offering Prospectus And Applies For Dual Listing on Canadian Securities Exchange

MariMed Files Preliminary Non-Offering Prospectus And Applies For Dual Listing on Canadian Securities Exchange

NORWOOD, Mass., April 07, 2022 -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced that it has filed a preliminary non-offering long form prospectus (the “Prospectus”) with the securities regulatory authorities in the Provinces of Ontari... Read More...
MariMed to Participate in April Investor Conferences

MariMed to Participate in April Investor Conferences

NORWOOD, Mass., March 23, 2022 -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced its participation in the following cannabis upcoming conferences: BTIG Global Cannabis Conference: CEO and President Bob Fireman will participate in a fir... Read More...
MariMed Doubles Full Year Revenue and Adjusted EBITDA As It Reports Fourth Quarter and Full Year 2021 Earnings

MariMed Doubles Full Year Revenue and Adjusted EBITDA As It Reports Fourth Quarter and Full Year 2021 Earnings

NORWOOD, Mass., March 16, 2022 -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial and operating results for the fourth quarter and full year ended December 31, 2021. FOURTH QUARTER AND FULL YEAR FINANCIAL HIGHLIGHTS Fourth... Read More...
MariMed Adds Second Retail Location in Massachusetts With Acquisition of Adult-Use Dispensary in Beverly

MariMed Adds Second Retail Location in Massachusetts With Acquisition of Adult-Use Dispensary in Beverly

NORWOOD, Mass., March 08, 2022 -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it signed a definitive agreement to acquire a provisional dispensary license from Green House Naturals, LLC. The transaction, which is subject to customar... Read More...
MariMed To Acquire Illinois Craft Cannabis License Allowing for Vertically Integrated Cannabis Operations

MariMed To Acquire Illinois Craft Cannabis License Allowing for Vertically Integrated Cannabis Operations

NORWOOD, Mass., Jan. 18, 2022 -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it signed a definitive agreement to acquire Green Growth Group, Inc. (“Green Growth”), holder of a provisional Cannabis Craft License in Illinois. The tran... Read More...
MariMed Announces Agreement to Acquire Kind Therapeutics USA, LLC, A Maryland Licensed Vertically Integrated Cannabis Business

MariMed Announces Agreement to Acquire Kind Therapeutics USA, LLC, A Maryland Licensed Vertically Integrated Cannabis Business

NORWOOD, Mass., Jan. 05, 2022 -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced that it has entered into a definitive agreement to acquire Kind Therapeutics U.S.A., LLC (“Kind”), a leading vertically integrated cannabis business in Mary... Read More...
MariMed Unveils World's Largest Cannabis-Infused Brownie to Celebrate Launch of Its “Bubby's Baked” Brand

MariMed Unveils World’s Largest Cannabis-Infused Brownie to Celebrate Launch of Its “Bubby’s Baked” Brand

New line of soft, chewy edibles hits shelves just in time for National Brownie Day and the holiday “baking” season NORWOOD, Mass., Dec. 07, 2021 -- MariMed, Inc. (OTCQX: MRMD) ("MariMed''), a leading multi-state cannabis operator focused on improving lives every day, today unveiled the world’s largest cannabis-infused brownie in celebrati... Read More...
MariMed Wins Four Awards on the 2021 LeafLink List for Its Brands and Dispensaries

MariMed Wins Four Awards on the 2021 LeafLink List for Its Brands and Dispensaries

NORWOOD, Mass., Nov. 18, 2021 -- MariMed, Inc. (OTCQX: MRMD) ("MariMed"), a leading multi-state cannabis operator focused on improving lives every day, announced today that its brands and dispensaries earned four wins on the 2021 LeafLink List, LeafLink’s annual awards honoring the standout cannabis brands, products, and retailers. MariMe... Read More...
MariMed Wins High Times Cultivation Cup Award for Its Nature's Heritage Brand and MetroSouth Award for Best Dispensary

MariMed Wins High Times Cultivation Cup Award for Its Nature’s Heritage Brand and MetroSouth Award for Best Dispensary

NORWOOD, Mass., Nov. 04, 2021 -- MariMed, Inc. (OTCQX: MRMD) ("MariMed"), a leading multi-state cannabis operator focused on improving lives every day, continued its winning streak of earning industry recognition for its high-quality products and dispensaries. In a competition this week of the best flower produced in the state, the Compan... Read More...
MariMed Announces Appointment of Steve West as Vice President, Investor Relations

MariMed Announces Appointment of Steve West as Vice President, Investor Relations

NORWOOD, Mass., Sept. 27, 2021 -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced the appointment of Steve West as Vice President, Investor Relations. He brings to MariMed nearly 20 years of capital markets experience as an investor rel... Read More...
Coming Soon.
IndexLast% Change
------
------
------
------

Delayed data (1h)
IndexLast% Change
------
------
------
------


Share this page